Biostar Announces Board of Directors Approval of Q1 2026 Consolidated Financial Report

1. Date of reporting to the board of directors or resolution by the board of directors: 2026/05/13 2. Date of approval by the audit committee: 2026/05/13 3. Reporting period of financial report or annual self-compiled financial information: 2026/01/01~2026/03/31 4. Accumulated operating revenue from January 1 to the end of the current period (in thousands of NTD): 434,635 5. Accumulated operating gross profit (gross loss) from January 1 to the end of the current period (in thousands of NTD): 71,576 6. Accumulated operating income (loss) from January 1 to the end of the current period (in thousands of NTD): (38,003) 7. Accumulated profit (loss) before tax from January 1 to the end of the current period (in thousands of NTD): 293,376 8. Accumulated net profit (net loss) for the current period from January 1 to the end of the current period (in thousands of NTD): 263,140 9. Accumulated net profit (loss) attributable to owners of the parent from January 1 to the end of the current period (in thousands of NTD): 263,140 10. Accumulated basic earnings (loss) per share from January 1 to the end of the current period (in NTD): 1.48 11. Total assets at the end of the period (in thousands of NTD): 3,098,844 12. Total liabilities at the end of the period (in thousands of NTD): 636,030 13. Equity attributable to owners of the parent at the end of the period (in thousands of NTD): 2,462,814 14. Other matters that should be specified: None Keywords: Material Information